Stock Scorecard
Stock Summary for Pfizer Inc (PFE) - $22.28 as of 5/12/2025 3:54:58 PM EST
Total Score
12 out of 30
Safety Score
64 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PFE
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PFE
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PFE
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for PFE
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for PFE (64 out of 100)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 6 |
| Book Value to Price (Max of 10) | 1 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 8 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 8 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for PFE
Financial Details for PFE
Company Overview |
|
|---|---|
| Ticker | PFE |
| Company Name | Pfizer Inc |
| Country | USA |
| Description | Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 7/28/2025 |
Stock Price History |
|
| Last Day Price | 22.28 |
| Price 4 Years Ago | 49.75 |
| Last Day Price Updated | 5/12/2025 3:54:58 PM EST |
| Last Day Volume | 77,237,466 |
| Average Daily Volume | 56,000,964 |
| 52-Week High | 29.98 |
| 52-Week Low | 20.53 |
| Last Price to 52 Week Low | 8.52% |
Valuation Measures |
|
| Trailing PE | 16.73 |
| Industry PE | 30.10 |
| Sector PE | 47.92 |
| 5-Year Average PE | 13.51 |
| Free Cash Flow Ratio | 89.12 |
| Industry Free Cash Flow Ratio | 18.49 |
| Sector Free Cash Flow Ratio | 30.82 |
| Current Ratio Most Recent Quarter | 0.56 |
| Total Cash Per Share | 0.25 |
| Book Value Per Share Most Recent Quarter | 15.89 |
| Price to Book Ratio | 1.45 |
| Industry Price to Book Ratio | 35.42 |
| Sector Price to Book Ratio | 27.83 |
| Price to Sales Ratio Twelve Trailing Months | 2.10 |
| Industry Price to Sales Ratio Twelve Trailing Months | 89.39 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.47 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 5,685,370,000 |
| Market Capitalization | 126,670,043,600 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 5/9/2025 |
| Previous Dividend Amount | 0.4300 |
| Current Dividend Amount | 0.4300 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 1.70 |
| Trailing Annual Dividend Yield | 7.36% |
| Forward Annual Dividend Rate | 1.72 |
| Forward Annual Dividend Yield | 7.45% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 6.56% |
| 5-Year Average Dividend Yield | 4.89% |
| 1-Year Dividend Growth Rate Percentage | 2.38% |
| 3-Year Dividend Growth Rate Percentage | 1.18% |
| 5-Year Dividend Growth Rate Percentage | 2.47% |
| All-Time Dividend Growth Rate Percentage | 8.79% |
| Dividend Payout Ratio | 123.19% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -5.30% |
| Annual Earnings Growth | 279.00% |
| Reported EPS 12 Trailing Months | 1.38 |
| Reported EPS Past Year | 0.92 |
| Reported EPS Prior Year | 3.11 |
| Net Income Twelve Trailing Months | 7,866,000,000 |
| Net Income Past Year | 8,031,000,000 |
| Net Income Prior Year | 2,119,000,000 |
| Quarterly Revenue Growth YOY | -7.80% |
| 5-Year Revenue Growth | 4.22% |
| Operating Margin Twelve Trailing Months | 35.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,430,000,000 |
| Total Cash Past Year | 1,043,000,000 |
| Total Cash Prior Year | 2,853,000,000 |
| Net Cash Position Most Recent Quarter | -55,390,000,000 |
| Net Cash Position Past Year | -55,660,000,000 |
| Long Term Debt Past Year | 56,703,000,000 |
| Long Term Debt Prior Year | 60,499,000,000 |
| Total Debt Most Recent Quarter | 56,820,000,000 |
| Equity to Debt Ratio Past Year | 0.61 |
| Equity to Debt Ratio Most Recent Quarter | 0.61 |
| Total Stockholder Equity Past Year | 88,203,000,000 |
| Total Stockholder Equity Prior Year | 89,014,000,000 |
| Total Stockholder Equity Most Recent Quarter | 88,497,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 11,220,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.97 |
| Free Cash Flow Past Year | 9,835,000,000 |
| Free Cash Flow Prior Year | 4,793,000,000 |
Options |
|
| Put/Call Ratio | 0.67 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.15 |
| MACD Signal | -0.29 |
| 20-Day Bollinger Lower Band | 21.97 |
| 20-Day Bollinger Middle Band | 25.11 |
| 20-Day Bollinger Upper Band | 28.24 |
| Beta | 0.50 |
| RSI | 43.64 |
| 50-Day SMA | 26.46 |
| 150-Day SMA | 31.78 |
| 200-Day SMA | 34.44 |
System |
|
| Modified | 5/13/2025 8:11:19 AM EST |